Application 022454

Type
NDA
Sponsor
GE HLTHCARE INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DATSCANIOFLUPANE I-123SOLUTION;INTRAVENOUS5mCi/2.5ML (2mCi/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent
17156-210DaTscanIoflupane I-123Medi-Physics Inc. dba GE Healthcare.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85706SUPPL 2026-04-17
85700SUPPL 2026-04-16
72772SUPPL2022-12-05
72759SUPPL2022-12-01
72548SUPPL2022-11-02
72534SUPPL2022-11-02
62346SUPPL2020-03-26
62343SUPPL2020-03-26
38722SUPPL2015-09-11
29739SUPPL2015-09-11
23083SUPPL2015-09-11
38721ORIG2015-07-28
44756ORIG2011-02-17
22024ORIG2011-02-16
29738ORIG2011-01-20